134 related articles for article (PubMed ID: 9029665)
1. Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder.
O'Donnell MC; Catts SV; Ward PB; Liebert B; Lloyd A; Wakefield D; McConaghy N
Psychiatry Res; 1996 Dec; 65(3):171-8. PubMed ID: 9029665
[TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
[TBL] [Abstract][Full Text] [Related]
3. Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression.
Maes M; Meltzer HY; Buckley P; Bosmans E
Eur Arch Psychiatry Clin Neurosci; 1995; 244(6):325-9. PubMed ID: 7772617
[TBL] [Abstract][Full Text] [Related]
4. Exploration of dimensions of psychopathology in neuroleptic-naïve patients with recent-onset schizophrenia/schizophreniform disorder.
John JP; Khanna S; Thennarasu K; Reddy S
Psychiatry Res; 2003 Nov; 121(1):11-20. PubMed ID: 14572620
[TBL] [Abstract][Full Text] [Related]
5. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania.
Tsai SY; Yang YY; Kuo CJ; Chen CC; Leu SJ
J Affect Disord; 2001 May; 64(2-3):185-93. PubMed ID: 11313085
[TBL] [Abstract][Full Text] [Related]
6. Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and IL-1 receptor antagonist in schizophrenic patients.
Sirota P; Meiman M; Herschko R; Bessler H
Psychiatry Res; 2005 Apr; 134(2):151-9. PubMed ID: 15840416
[TBL] [Abstract][Full Text] [Related]
7. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
[TBL] [Abstract][Full Text] [Related]
8. Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia.
Rapaport MH; Lohr JB
Acta Psychiatr Scand; 1994 Nov; 90(5):311-5. PubMed ID: 7872033
[TBL] [Abstract][Full Text] [Related]
9. Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.
Szymona K; Zdzisińska B; Karakuła-Juchnowicz H; Kocki T; Kandefer-Szerszeń M; Flis M; Rosa W; Urbańska EM
Neurotox Res; 2017 Jul; 32(1):17-26. PubMed ID: 28275903
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms.
Ganguli R; Brar JS; Chengappa KR; DeLeo M; Yang ZW; Shurin G; Rabin BS
Arch Gen Psychiatry; 1995 Aug; 52(8):668-72. PubMed ID: 7632120
[TBL] [Abstract][Full Text] [Related]
11. Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment.
Arolt V; Rothermundt M; Wandinger KP; Kirchner H
Mol Psychiatry; 2000 Mar; 5(2):150-8. PubMed ID: 10822342
[TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers.
Sun A; Chu CT; Liu BY; Wang JT; Leu JS; Chiang CP
Proc Natl Sci Counc Repub China B; 2000 Jul; 24(3):116-22. PubMed ID: 10943944
[TBL] [Abstract][Full Text] [Related]
13. Soluble interleukin 2 receptor levels in acute and stable schizophrenia.
Gaughran F; O'Neill E; Sham P; Daly RJ; Shanahan F
Schizophr Res; 2001 Oct; 52(1-2):143-4. PubMed ID: 11595403
[No Abstract] [Full Text] [Related]
14. Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine.
Maes M; Meltzer HY; Bosmans E
Acta Psychiatr Scand; 1994 May; 89(5):346-51. PubMed ID: 8067274
[TBL] [Abstract][Full Text] [Related]
15. Persistently increased serum soluble interleukin-2 receptors in continuously ill patients with schizophrenia.
Bresee C; Rapaport MH
Int J Neuropsychopharmacol; 2009 Jul; 12(6):861-5. PubMed ID: 19366488
[TBL] [Abstract][Full Text] [Related]
16. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology.
Zhang XY; Zhou DF; Zhang PY; Wu GY; Cao LY; Shen YC
Schizophr Res; 2002 Oct; 57(2-3):247-58. PubMed ID: 12223256
[TBL] [Abstract][Full Text] [Related]
17. Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia.
O'Brien SM; Scully P; Dinan TG
Psychiatry Res; 2008 Sep; 160(3):256-62. PubMed ID: 18722671
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia.
Müller N; Empl M; Riedel M; Schwarz M; Ackenheil M
Eur Arch Psychiatry Clin Neurosci; 1997; 247(6):308-13. PubMed ID: 9477010
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders.
Katila H; Appelberg B; Hurme M; Rimón R
Schizophr Res; 1994 Apr; 12(1):29-34. PubMed ID: 8018583
[TBL] [Abstract][Full Text] [Related]
20. An association between anti-hippocampal antibody concentration and lymphocyte production of IL-2 in patients with schizophrenia.
Yang ZW; Chengappa KN; Shurin G; Brar JS; Rabin BS; Gubbi AV; Ganguli R
Psychol Med; 1994 May; 24(2):449-55. PubMed ID: 8084939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
